Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 2
1991 2
1993 1
1994 3
1995 3
1996 2
1997 4
1998 4
1999 4
2000 7
2001 6
2002 2
2003 3
2004 4
2005 6
2006 8
2007 7
2008 8
2009 9
2010 12
2011 4
2012 2
2013 7
2014 6
2015 8
2016 6
2017 5
2018 5
2019 3
2020 10
2021 7
2022 5
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Results by year

Filters applied: . Clear all
Page 1
Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach.
Jung CK, Bychkov A, Kakudo K. Jung CK, et al. Endocrinol Metab (Seoul). 2022 Oct;37(5):703-718. doi: 10.3803/EnM.2022.1553. Epub 2022 Oct 4. Endocrinol Metab (Seoul). 2022. PMID: 36193717 Free PMC article. Review.
The terms "follicular nodular disease" and "differentiated high-grade thyroid carcinoma" are introduced to account for multifocal hyperplastic/neoplastic lesions and differentiated thyroid carcinomas with high-grade features, respectively. ...Invasive encapsu …
The terms "follicular nodular disease" and "differentiated high-grade thyroid carcinoma" are introduced to account for multifo …
Thyroid Nodules: Advances in Evaluation and Management.
Kant R, Davis A, Verma V. Kant R, et al. Am Fam Physician. 2020 Sep 1;102(5):298-304. Am Fam Physician. 2020. PMID: 32866364 Free article. Review.
After thyroid ultrasonography has been performed, the next step is measurement of serum thyroid-stimulating hormone. ...Molecular testing can be used to guide treatment when aspiration yields an indeterminate result. Molecular testing detects mutations associated wi …
After thyroid ultrasonography has been performed, the next step is measurement of serum thyroid-stimulating hormone. ...Molecu …
Thyroid carcinoma.
Sherman SI. Sherman SI. Lancet. 2003 Feb 8;361(9356):501-11. doi: 10.1016/s0140-6736(03)12488-9. Lancet. 2003. PMID: 12583960 Review.
Thyroid carcinomas are fairly uncommon and include disease types that range from indolent localised papillary carcinomas to the fulminant and lethal anaplastic disease. Several attempts to formulate a consensus about treatment of thyroid carcinoma have …
Thyroid carcinomas are fairly uncommon and include disease types that range from indolent localised papillary carcinomas to th …
Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Fallahi P, Ferrari SM, Galdiero MR, Varricchi G, Elia G, Ragusa F, Paparo SR, Benvenga S, Antonelli A. Fallahi P, et al. Semin Cancer Biol. 2022 Feb;79:180-196. doi: 10.1016/j.semcancer.2020.11.013. Epub 2020 Nov 26. Semin Cancer Biol. 2022. PMID: 33249201 Review.
Thyroid cancer (TC) is the eighth most frequently diagnosed cancer worldwide with a rising incidence in the past 20 years. ...During tumor progression, the iodide uptake capability of DTC cancer cells can be lost, making them refractory to RAI, with a …
Thyroid cancer (TC) is the eighth most frequently diagnosed cancer worldwide with a rising incidence in the past 20 yea …
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S, Yim S, Park H. Chang S, et al. Exp Mol Med. 2019 Jun 20;51(6):1-17. doi: 10.1038/s12276-019-0230-6. Exp Mol Med. 2019. PMID: 31221981 Free PMC article. Review.
Recent studies on mutations in cancer genomes have distinguished driver mutations from passenger mutations, which occur as byproducts of cancer development. ...We have also discussed mutations in other isoforms such as the JARID1A, 1B, 1D of KDM5 subfamilies and the …
Recent studies on mutations in cancer genomes have distinguished driver mutations from passenger mutations, which occur as byproducts …
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P. Antonelli A, et al. Autoimmun Rev. 2014 Mar;13(3):272-80. doi: 10.1016/j.autrev.2013.10.010. Epub 2013 Nov 2. Autoimmun Rev. 2014. PMID: 24189283 Review.
The secretion of CXCL10 by cluster of differentiation (CD)4+, CD8+, natural killer (NK) and NK-T cells is dependent on interferon (IFN)-gamma, which is itself mediated by the interleukin-12 cytokine family. Under the influence of IFN-gamma, CXCL10 is secreted by several ce …
The secretion of CXCL10 by cluster of differentiation (CD)4+, CD8+, natural killer (NK) and NK-T cells is dependent on interferon (IFN)-gamm …
Hereditary and familial thyroid tumours.
Guilmette J, Nosé V. Guilmette J, et al. Histopathology. 2018 Jan;72(1):70-81. doi: 10.1111/his.13373. Histopathology. 2018. PMID: 29239041 Review.
Familial thyroid cancers arising from follicular cells are referred to as familial non-medullary thyroid carcinoma (FNMTC), or familial follicular cell-derived carcinoma. ...The second group encompasses a spectrum of familial …
Familial thyroid cancers arising from follicular cells are referred to as familial non-medullary thyroid carc …
An update on familial nonmedullary thyroid cancer.
Ammar SA, Alobuia WM, Kebebew E. Ammar SA, et al. Endocrine. 2020 Jun;68(3):502-507. doi: 10.1007/s12020-020-02250-3. Epub 2020 Mar 11. Endocrine. 2020. PMID: 32162184 Review.
Familial nonmedullary thyroid cancer (FNMTC) constitutes 3-9% of all thyroid cancer cases. ...Nonsyndromic FNMTC is more common as compared with syndromic FNMTC. In syndromic FNMTC, patients are at risk of nonmedullary thyroid …
Familial nonmedullary thyroid cancer (FNMTC) constitutes 3-9% of all thyroid cancer cases. ...Nons …
Familial nonmedullary thyroid cancer: screening, clinical, molecular and genetic findings.
Navas-Carrillo D, Ríos A, Rodríguez JM, Parrilla P, Orenes-Piñero E. Navas-Carrillo D, et al. Biochim Biophys Acta. 2014 Dec;1846(2):468-76. doi: 10.1016/j.bbcan.2014.09.002. Epub 2014 Sep 11. Biochim Biophys Acta. 2014. PMID: 25218916 Review.
Familial thyroid cancer has become a well-recognized, unique, clinical entity in patients with thyroid cancer originating from follicular cells, that is, nonmedullary thyroid carcinoma. Hereditary nonmedullary thyr …
Familial thyroid cancer has become a well-recognized, unique, clinical entity in patients with thyroid cancer …
Second generation of familial nonmedullary thyroid carcinoma: A meta-analysis on the clinicopathologic features and prognosis.
Zhou YM, Luo H, Gou JX, Zhao WJ, Dai WY, Zhu J, Li ZH. Zhou YM, et al. Eur J Surg Oncol. 2017 Dec;43(12):2248-2256. doi: 10.1016/j.ejso.2017.09.005. Epub 2017 Sep 12. Eur J Surg Oncol. 2017. PMID: 28942234 Review.
Whether the second generation of parent/offspring type familial nonmedullary thyroid carcinoma (FNMTC) is more aggressive and has worse prognosis than their first generation counterpart is controversial. ...The Q-test and I(2) test were used to evaluat …
Whether the second generation of parent/offspring type familial nonmedullary thyroid carcinoma (FNMTC) is more a …
157 results